By: Eric Ng
Lung-cancer drug ivonescimab is ‘potentially two to three years ahead of competitors’, analyst says.
Eric Ng is a News Editor at the Climate section of the Post. With over 20 years of experience, he specializes in covering China's energy, mining, and industrial materials sectors, while also focusing on climate change, energy transition, and sustainability topics. Eric has been featured in PCMag, Newswav, The Star Online, MSN, South China Morning Post SCMP, BioRxiv, NationAfrica, Car Design News, nstonline, and Focus Malaysia.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston


Not enough data
Eric Ng's coverage mainly revolves around the business, energy, finance & economy themes with a focus on climate change, renewable energy, carbon credits, climate finance and sustainability. He often covers government and private sector announcements related to these topics.
To effectively reach out to Eric Ng, consider providing insights or data regarding the latest developments in renewable energy projects, innovative climate finance initiatives or significant policy changes related to sustainability. Additionally, offering perspectives from industry experts on key issues such as net-zero action by firms in Asia-Pacific or decarbonization efforts ahead of COP28 would likely capture his attention.
It is important to note that while Eric's coverage seems focused internationally based on the nature of his articles' content (COP28), he doesn't explicitly specify any specific geographic focus. Therefore, tailor pitches with a global perspective but highlight relevant regional impacts when applicable.
This information evolves through artificial intelligence and human feedback. Improve this profile .